UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center
UCSF navigation bar
  UCSF arrow indicating deeper hierarchy A-Z Index of Webs arrow indicating deeper hierarchy U arrow indicating deeper hierarchyDepartment of Urology arrow indicating deeper hierarchyFaculty arrow indicating deeper hierarchy Rajvir Dahiya, PhD  
Department of Urology   search
Department of Urology

Rajvir Dahiya, PhD

Recent Publications

Publications – 2008

Basak, S., D. Pookot, E.J. Noonan, and R. Dahiya, Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function. Mol Cancer Ther, 2008. 7(10): p. 3195-202.
Chen, Z., R.F. Place, Z.J. Jia, D. Pookot, R. Dahiya, and L.C. Li, Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther, 2008. 7(3): p. 698-703.
Hirata, H., Y. Hinoda, N. Okayama, Y. Suehiro, K. Kawamoto, N. Kikuno, J.T. Rabban, L.M. Chen, and R. Dahiya, COMT polymorphisms affecting protein expression are risk factors for endometrial cancer. Mol Carcinog, 2008.
Hirata, H., Y. Hinoda, N. Okayama, Y. Suehiro, K. Kawamoto, N. Kikuno, J.T. Rabban, L.M. Chen, and R. Dahiya, CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer, 2008.
Hirata, H., Y. Hinoda, K. Kawamoto, N. Kikuno, Y. Suehiro, N. Okayama, Y. Tanaka, and R. Dahiya, Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer. J Urol, 2008. 179(5): p. 2020-4.
Kawamoto, K., H. Hirata, N. Kikuno, Y. Tanaka, M. Nakagawa, and R. Dahiya, DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int J Cancer, 2008. 123(3): p. 535-42.
Kikuno, N., H. Shiina, S. Urakami, K. Kawamoto, H. Hirata, Y. Tanaka, S. Majid, M. Igawa, and R. Dahiya, Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer, 2008. 123(3): p. 552-60.
Kikuno, N., K. Kawamoto, H. Hirata, K. Vejdani, K. Kawakami, T. Fandel, L. Nunes, S. Urakami, H. Shiina, M. Igawa, E. Tanagho, and R. Dahiya, Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder. BJU Int, 2008.
Majid, S., N. Kikuno, J. Nelles, E. Noonan, Y. Tanaka, K. Kawamoto, H. Hirata, L.C. Li, H. Zhao, S.T. Okino, R.F. Place, D. Pookot, and R. Dahiya, Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res, 2008. 68(8): p. 2736-44.
Place, R.F., L.C. Li, D. Pookot, E.J. Noonan, and R. Dahiya, MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A, 2008. 105(5): p. 1608-13.
Ueno, K., M. Hiura, Y. Suehiro, S. Hazama, H. Hirata, M. Oka, K. Imai, R. Dahiya, and Y. Hinoda, Frizzled-7 as a potential therapeutic target in colorectal cancer. Neoplasia, 2008. 10(7): p. 697-705.
 

Publications – 2007

Hirata, H., Y. Hinoda, N. Kikuno, K. Kawamoto, A.V. Dahiya, Y. Suehiro, Y. Tanaka, and R. Dahiya, CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res, 2007. 13(17): p. 5056-62.
Hirata, H., Y. Hinoda, N. Kikuno, K. Kawamoto, Y. Suehiro, Y. Tanaka, and R. Dahiya, MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Clin Cancer Res, 2007. 13(14): p. 4123-9.
Hirata, H., Y. Hinoda, Y. Tanaka, N. Okayama, Y. Suehiro, K. Kawamoto, N. Kikuno, S. Majid, K. Vejdani, and R. Dahiya, Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer, 2007. 43(2): p. 231-7.
Kawamoto, K., S.T. Okino, R.F. Place, S. Urakami, H. Hirata, N. Kikuno, T. Kawakami, Y. Tanaka, D. Pookot, Z. Chen, S. Majid, H. Enokida, M. Nakagawa, and R. Dahiya, Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer. Clin Cancer Res, 2007. 13(9): p. 2541-8.
Kikuno, N., H. Shiina, S. Urakami, K. Kawamoto, H. Hirata, Y. Tanaka, R.F. Place, D. Pookot, S. Majid, M. Igawa, and R. Dahiya, Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene, 2007. 26(55): p. 7647-55.
Li, L.C. and R. Dahiya, Epigenetics of prostate cancer. Front Biosci., 2007. May 1(12): p. 3377-97.
Okino, S.T., D. Pookot, S. Majid, H. Zhao, L.C. Li, R.F. Place, and R. Dahiya, Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol Carcinog, 2007. 46(10): p. 839-46.
Okino, S.T., L.C. Quattrochi, D. Pookot, M. Iwahashi, and R. Dahiya, A dioxin-responsive enhancer 3' of the human CYP1A2 gene. Mol Pharmacol, 2007. 72(6): p. 1457-65.
Qin, J., L.P. Xie, X.Y. Zheng, Y.B. Wang, Y. Bai, H.F. Shen, L.C. Li, and R. Dahiya, A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun, 2007. 354(4): p. 852-7.
Tanaka, Y., H. Hirata, Z. Chen, N. Kikuno, K. Kawamoto, S. Majid, T. Tokizane, S. Urakami, H. Shiina, K. Nakajima, R. Dhir, and R. Dahiya, Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer. Cancer Epidemiol Biomarkers Prev, 2007. 16(1): p. 92-7.
Urakami, S., H. Shiina, H. Enokida, K. Kawamoto, N. Kikuno, T. Fandel, K. Vejdani, L. Nunes, M. Igawa, E.A. Tanagho, and R. Dahiya, Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the rat. World J Urol, 2007. 25(2): p. 207-13.